ZURICH (Reuters) - Swiss drugmaker Roche said on Monday that a cocktail of its immunotherapy Tecentriq with chemotherapy boosted survival of patients with previously untreated extensive-stage small cell lung cancer compared with chemotherapy alone. ...
Original Article: Roche's Tecentriq cocktail boosts survival in small cell lung cancer